|
Validation of the performance of the Decipher biopsy genomic classifier in intermediate-risk prostate cancer on the phase III randomized trial NRG Oncology/RTOG 0126. |
|
|
Honoraria - Varian Medical Systems |
Consulting or Advisory Role - AstraZeneca; Boston Scientific; Janssen Oncology |
Research Funding - Janssen (Inst) |
|
|
Employment - Decipher Biosciences |
Stock and Other Ownership Interests - Decipher Biosciences |
|
|
Consulting or Advisory Role - Boston Scientific |
Research Funding - Merck Sharp & Dohme; Novartis; POINT Biopharma; Progenics |
Travel, Accommodations, Expenses - Boston Scientific |
|
|
Employment - Decipher Biosciences |
Stock and Other Ownership Interests - Decipher Biosciences |
Patents, Royalties, Other Intellectual Property - Decipher Biosciences |
|
|
Consulting or Advisory Role - Abbvie; Astellas Pharma; Ferring |
Research Funding - Abbvie |
|
|
Stock and Other Ownership Interests - 3D Biopsy; Abbvie; Gilead Sciences; Lightspeed microscopy; Protean Biodiagnostics |
Research Funding - Intuitive Surgical (Inst) |
|
|
Consulting or Advisory Role - AstraZeneca; Blue Earth Diagnostics; Boston Scientific; Merck; Myovant Sciences; Roivant |
|
|
Honoraria - Reflexion Medical |
Consulting or Advisory Role - Astellas Pharma; AstraZeneca; Dendreon; GenomeDx; Janssen; Myovant Sciences; Noxopharm; Reflexion Medical; Reflexion Medical; Regeneron |
Research Funding - Astellas Pharma (Inst); Bayer Health (Inst); Reflexion Medical (Inst) |
Patents, Royalties, Other Intellectual Property - Compounds and Methods of Use in Ablative Radiotherapy. Patent filed 3/9/2012. PCT/US2012/028475. PCT/WO/2012/122471. |
Travel, Accommodations, Expenses - Reflexion Medical |
|
|
Consulting or Advisory Role - Decipher Biosciences |
|
|
No Relationships to Disclose |
|
|
Honoraria - Abbvie; Verity Pharmaceuticals |
|
|
No Relationships to Disclose |
|
|
No Relationships to Disclose |
|
|
No Relationships to Disclose |
|
|
No Relationships to Disclose |
|
|
No Relationships to Disclose |
|
|
No Relationships to Disclose |
|
|
No Relationships to Disclose |
|
|
Stock and Other Ownership Interests - Artera |
Consulting or Advisory Role - Astellas Pharma; Bayer; Bristol Myers Squibb; Exact Sciences; Foundation Medicine; Janssen Biotech; Myovant Sciences; Novartis; Roivant; SerImmune; Varian Medical Systems |
Research Funding - Zenith Epigenetics |